Connect with us

Published

on

Actor James Norton, who stars in a new film telling the story of the world’s first “test-tube baby”, has criticised how “prohibitively expensive” IVF can be in the UK.

In Joy, the star portrays the real-life scientist Bob Edwards, who – along with obstetrician Patrick Steptoe and embryologist Jean Purdy – spent a decade tirelessly working on medical ways to help infertility.

The film charts the 10 years leading up to the birth of Louise Joy Brown, who was dubbed the world’s first test-tube baby, in 1978.

James Norton stars in Joy. Pic: Kerry Brown/ Netflix
Image:
In the UK, statistics show the proportion of IVF cycles paid for by the NHS has dropped from 40% to 27% in the last decade

Norton, who is best known for playing Tommy Lee Royce in the BAFTA-winning series Happy Valley, told Sky News he has friends who were IVF babies and other friends who have had their own children thanks to the fertility treatment.

“But I didn’t know about these three scientists and their sacrifice, tenacity and skill,” he said. The star hopes the film will be “a catalyst for conversation” about the treatment and its availability.

“We know for a fact that Jean, Bob and Patrick would not have liked the fact that IVF is now so means based,” he said. “It’s prohibitively expensive for some… and there is a postcode lottery which means that some people are precluded from that opportunity.”

Bill Nighy, Thomasin McKenzie and James Norton star in Joy. Pic: Netflix/ Kerry Brown
Image:
Bill Nighy, Thomasin McKenzie and James Norton star in Joy. All pics: Netflix/ Kerry Brown

Now, IVF is considered a wonder of modern medicine. More than 12 million people owe their existence today to the treatment Edwards, Steptoe and Purdy worked so hard to devise.

But Joy shows how public backlash in the years leading up to Louise’s birth saw the team vilified – accused of playing God and creating “Frankenstein babies”.

Bill Nighy and Thomasin McKenzie star alongside Norton, with the script written by acclaimed screenwriter Jack Thorne and his wife Rachel Mason.

The couple went through seven rounds of IVF themselves to conceive their son.

James Norton and Thomasin McKenzie star in Joy. Pic: Kerry Brown/ Netflix
Image:
Norton portrays scientist Bob Edwards, while McKenzie plays embryologist Jean Purdy

While the film is set in the 1970s, the reality is that societal pressures haven’t changed all that much for many going through IVF today – with the costs now both emotional and financial.

“IVF is still seen as a luxury product, as something that some people get access to and others don’t,” said Thorne, speaking about their experiences in the UK.

“Louise was a working-class girl with working-class parents. Working class IVF babies are very, very rare now.”

In the run-up to the US election, Donald Trump saw IVF as a campaigning point – promising his government, or insurance companies, would pay for the treatment for all women should he be elected. He called himself the “father of IVF” at a campaign event – a remark described as “quite bizarre” by Kamala Harris.

Please use Chrome browser for a more accessible video player

Bill Nighy ‘proud’ of new film on IVF breakthrough

“I don’t think Trump is a blueprint for this,” Norton said. “I don’t know how that fits alongside his questions around pro-choice.”

Read more:
Boy George on the price of fame
The fan club president who joined the band

In the UK, statistics from fertility regulator HEFA show the proportion of IVF cycles paid for by the NHS has dropped from 40% to 27% in the last decade.

“It’s so expensive,” Norton said. “Those who want a child should have that choice… and some people’s lack of access to this incredibly important science actually means that people don’t have the choice.”

Joy is in UK cinemas from 15 November, and on Netflix from 22 November

Continue Reading

UK

Hundreds of barbers, car washes and American sweet shops raided in money laundering crackdown

Published

on

By

Hundreds of barbers, car washes and American sweet shops raided in money laundering crackdown

Hundreds of barber shops and other cash-heavy businesses have been targeted in a three-week money laundering blitz.

Police went to 265 premises, including vape shops, nail bars, American-themed sweet shops and car washes across England in a crackdown on high street crime.

The National Crime Agency (NCA) said 35 arrests were made, 97 people suspected to be victims of modern slavery were placed under police protection, and bank accounts containing more than £1m were frozen.

More than £40,000 in cash, some 200,000 cigarettes, 7,000 packs of tobacco, and more than 8,000 illegal vapes were also seized during Operation Machinize, which involved 19 different police forces and regional organised crime units.

Officers also found two cannabis farms containing a total of 150 plants, while 10 shops have been shut down.

The NCA estimates that £12bn of criminal cash is generated in the UK each year with businesses such as barber shops, vape shops, nail bars, American-themed sweet shops and car washes often used by criminals.

Goods seized during their visit to a vape shop in Rochdale.
Pic: GMP/PA
Image:
Goods seized during a visit to a vape shop in Rochdale. Pic: GMP/PA

Police officers at a shop in Tameside. 
Pic: GMP/PA
Image:
Police officers at a shop in Tameside. Pic: GMP/PA

Rachael Herbert, deputy director of the National Economic Crime Centre at the NCA, said: “Operation Machinize targeted barber shops and other high street businesses being used as cover for a whole range of criminality, all across the country.

More from UK

“We have seen links to drug trafficking and distribution, organised immigration crime, modern slavery and human trafficking, firearms, and the sale of illicit tobacco and vapes.

“We know cash-intensive businesses are used as fronts for money laundering, facilitating some of the highest harm and highest impact offending in the UK.”

Pic: NCA
Image:
Money laundering crackdown. Pic: NCA

Security minister Dan Jarvis said the operation “highlights the scale and complexity of the criminality our towns and cities face”.

“High street crime undermines our security, our borders, and the confidence of our communities, and I am determined to take the decisive action necessary to bring those responsible to justice,” he said.

Continue Reading

UK

Kara Alexander: Dagenham mother who murdered her two young sons in the bath jailed

Published

on

By

Kara Alexander: Dagenham mother who murdered her two young sons in the bath jailed

A skunk-smoking mother who murdered her two young sons in the bath while in a psychotic state has been jailed for life with a minimum term of more than 21 years.

Kara Alexander was found guilty of drowning Elijah Thomas, two, and Marley Thomas, five, at the home they shared in Dagenham, east London, in December 2022.

Alexander, 47, who had denied two counts of murder, was convicted at Kingston Crown Court in February.

Post-mortems on the boys found they had either been drowned or suffocated – but Alexander accepted at trial that she had placed them in the bath before they “accidentally” drowned.

Returning to Kingston Crown Court on Friday, Mr Justice Bennathan sentenced Alexander to life imprisonment with a minimum term of 21 years and 252 days.

The judge referred to the children’s father finding his deceased sons next to one another as “the stuff of nightmares”.

Mr Justice Bennathan said: “On the evening of 15 December 2022, you’d been smoking skunk.

“You’d been doing so every night for weeks, probably much longer. At some stage, both the boys were in their pyjamas ready for bed, with Elijah also wearing his nappy.

“You drowned them both by your deliberate acts.”

The judge said Alexander “unspeakably” held the boys under water for “up to a minute or two”.

“The bath was probably still run from their normal evening routine and I do not think for a moment that your dreadful acts were pre-meditated,” he said.

The judge said Alexander dried the boys, put them in clean pyjamas and laid them together, tucked in under duvets, on the same bunk bed.

“The next morning, their father, worried by your unusual silence, came and found them. The stuff of nightmares,” he said.

The jury heard how the boys’ father was due to have them that weekend and became increasingly concerned when he had not heard back from Alexander.

When he arrived at their home, she told him the children were upstairs sleeping.

When the father returned downstairs to call for help, Alexander had run away. It took the police around an hour to find her.

The Metropolitan Police said forensic analysis of Alexander’s phone, which had been found in a filled sink, showed it had been in regular use in the run-up to the murders, but on the day the children were found, no calls were made or messages sent.

This led detectives to believe that she had intentionally been avoiding people following their deaths.

Prosecutors said they built their case on showing the boys could not have accidentally drowned and that the only reasonable explanation for their deaths was that Alexander caused them to drown.

Read more from Sky News:
Family die in sightseeing helicopter crash
Man who murdered taxi driver after being refused cigarette is jailed

The judge said there was every sign Alexander was a “caring and affectionate” mother to both children before the events of 15 December 2022.

He pointed out that their father said Alexander “never shouted or raised her voice at the boys” and “never showed violence to the boys”.

The judge said: “From all that I have read and seen of you, I have no doubt that every day when you awake you will remember and grieve for the little boys whose lives you snatched away.”

Mr Justice Bennathan said Alexander was in a psychotic state when she killed her sons and that it was cannabis induced.

He said Alexander had a previous psychotic episode in 2016 in which cannabis also probably played a part, but acknowledged he could not be sure she was aware that the drug could trigger another psychotic state.

In his sentencing remarks, Mr Justice Bennathan warned of the dangers of drugs.

He said: “The heavy use of skunk or other hyper-strong strains of cannabis can plunge people into a mental health crisis in which they may harm themselves or others.

“If any drug user does not know that, it’s about time they did.

“At your trial, Kara Alexander, the three psychiatrists who gave evidence disagreed about a number of things, but on that they were unanimous.

“It will comfort nobody connected to this case, but if these events bring home that message to even a few people, some slight good may come from what is otherwise an unmitigated tragedy.”

Detective Chief Inspector Paul Waller, who led the investigation, said: “This is an incredibly tragic case, which has left a father without his two beloved boys and a family without two young brothers.

“Kara Alexander will spend the next two decades behind bars, where the memory of what she has done will haunt her forever.

“To the family and friends of Elijah and Marley, while no amount of time will erase the pain of such a loss, I hope this sentence serves to bring some semblance of justice.

“I hope you can now move on with your life, remembering the boys as you knew them, and treasuring the happy times you spent with them.”

Continue Reading

UK

‘I don’t look at myself as a dying person anymore’: New drug that slows incurable breast cancer now available on the NHS

Published

on

By

'I don't look at myself as a dying person anymore': New drug that slows incurable breast cancer now available on the NHS

A groundbreaking new cancer treatment, hailed by patients as “game-changing”, will be available via the NHS from today.

The drug capivasertib has been shown in trials to slow the spread of the most common form of incurable breast cancer.

Taken in conjunction with an already-available hormonal therapy, it has been shown in trials to double how long treatment will keep the cancer cells from progressing.

“I don’t look at myself anymore as a dying person,” says Elen Hughes, who has been using the drug since February this year.

“I look at myself as a thriving person, who will carry on thriving for as long as I possibly can.”

Ellen Hughes has been using the drug capivasertib
Image:
Elen Hughes says capivasertib has extended her life and improved its quality

Mrs Hughes, from North Wales, was first diagnosed with primary breast cancer in 2008.

Eight years later, then aged 46 and with three young children, she was told the cancer had returned and spread.

More on Cancer

She says that capivasertib, which she has been able to access via private healthcare, has not only extended her life but improved its quality with fewer side effects than previous medications.

It also delays the need for more aggressive blanket treatments like chemotherapy.

New breast cancer drug capivasertib
Image:
Capivasertib is now available from the NHS

“What people don’t understand is that they might look at the statistics and see that [the therapy] is effective for eight months versus two months, or whatever,” says Mrs Hughes.

“But in cancer, and the land that we live in, really we can do a lot in six months.”

Mrs Hughes says her cancer therapy has allowed her “to see my daughter get married” and believes it is “absolutely brilliant” that the new drug will be available to more patients via the NHS.

The National Institute for Health and Care Excellence approved capivasertib for NHS-use after two decades of research by UK teams.

Professor Nicholas Turner, from the Institute of Cancer Research which led the study, told Sky News it was a “great success story for British science”.

Professor Nicholas Turner, from the Institute of Cancer Research which led the study
Image:
Professor Nicholas Turner wants urgent genetic testing of patients with advanced breast cancers to see if they could benefit

The new drug is suitable for patients’ tumours with mutations or alterations in the PIK3CA, AKT1 or PTEN genes, which are found in approximately half of patients with advanced breast cancer.

Read more:
How AI could transform breast screening results
Breast cancer cases and deaths set to surge – study

Prof Turner says hundreds of patients could see the benefit in the immediate future, with thousands more people identified over time.

“We need new drugs that will help our existing therapies work for longer, and that’s where this new drug, capivasertib comes in,” says Prof Turner.

“It doubles how long hormone therapy treatment works for, giving patients precious extra time with their families.”

He called for urgent genetic testing of patients with advanced breast cancers to see if they could benefit.

Continue Reading

Trending